NovaDel, Pharmaceuticals Resources Inc. sales and marketing update

PRX subsidiary Par Pharmaceutical licensed exclusive U.S. and Canadian marketing and distribution rights to NVDL's nitroglycerin lingual spray to treat or prevent angina due to coronary artery diseas...